Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Local therapy improvement of outcome in a patient with recurrent hepatocellular carcinoma after living donor liver transplantation: a case report.

Anticancer research - 1 Jun 2015

Shimokawa Masahiro, Itoh Shinji, Ikegami Toru, Takeishi Kazuki, Harimoto Norifumi, Yamashita Yo-Ich, Yoshizumi Tomoharu, Kawanaka Hirofumi, Shirabe Ken, Maehara Yoshihiko

Abstract excerpt

We describe a very rare case of recurrent hepatocellular carcinoma (HCC) after living donor liver transplantation (LDLT). A 47-year-old female underwent LDLT for HCC within Milan criteria, receiving a left liver lobe from her 38-year-old husband with an incompatible blood type. Thirty months after LDLT, however, enhanced computed tomography (CT) showed a tumor in her left adrenal gland; after another six months,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to Liver Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Transplantation

Share to Living Donors

Share to Neoplasm Metastasis

Share to Neoplasm Recurrence, Local

Share to Positron-Emission Tomography

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 26026120

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Local therapy improvement of outcome in a patient with recurrent hepatocellular carcinoma after living donor liver transplantation: a case report.PMID 26026120Read ↗

High viremia, prolonged Lamivudine therapy and recurrent hepatocellular carcinoma predict posttransplant hepatitis B recurrence.Semantic proximity Read ↗

Prognosis in liver transplantation recipients after hepatitis B virus recurrence.Semantic proximity Read ↗

MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation.Semantic proximity Read ↗

Clinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients.Semantic proximity Read ↗

Hepatitis C virus recurrence in living donor liver transplant recipients.Semantic proximity Read ↗

"Preemptive" live donor liver transplantation for fibrolamellar hepatocellular carcinoma: a case report.Semantic proximity Read ↗

Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.Semantic proximity Read ↗

Donor Polymorphisms of Toll-like Receptor 4 rs1927914 Associated with the Risk of Hepatocellular Carcinoma Recurrence Following Liver Transplantation.Semantic proximity Read ↗

Retransplantation for recurrent hepatitis C.Semantic proximity Read ↗

Detection of p53 Mutations in Circulating DNA of Transplanted Hepatocellular Carcinoma Patients as a Biomarker of Tumor Recurrence.Semantic proximity Read ↗

Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation.Semantic proximity Read ↗

Donor origin of de novo hepatocellular carcinoma in hepatic allografts.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.